GlassScriptPhysician profile
Amit N Gogia
NPI 1831102185
$64,422.94
in general payments reported to CMS, 2019-2025
37 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $7,704 · 2021: $437 · 2022: $225 · 2023: $3,504 · 2024: $4,243 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Consulting Fee: $5,950 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,000.00 |
| Consulting Fee | $5,950.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,616.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36,638.95 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $23,427.12 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Medical Device Business Services, INC. | $1,398.49 | 2019 | |
| Baxter Healthcare | $1,256.67 | 2019-2020 | |
| Ethicon US, LLC | $328.22 | 2019-2025 | Echelon Flex, Enseal, Echelon; Endopath |
| Davol INC. | $227.71 | 2020-2025 | Phasix Mesh |
| Mimedx Group, INC. | $194.47 | 2025 | |
| Tela Bio, INC. | $128.23 | 2020 | |
| Mallinckrodt Hospital Products INC. | $93.38 | 2020 | |
| Innocoll Pharmaceuticals Limited | $53.74 | 2021-2022 | |
| Kerecis Limited | $47.33 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mallinckrodt Enterprises LLC | $46.70 | 2019 | |
| Z-Medica, LLC | $46.66 | 2020 | |
| Acell, INC. | $43.94 | 2019 | |
| Merck Sharp & Dohme LLC | $35.78 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $33.84 | 2022-2023 | Myrisk |
| Lifenet Health | $32.12 | 2024 | Theragenesis Wound Matrix |
| Karl Storz Endoscopy-America | $30.32 | 2019 | |
| Enterra Medical, INC. | $27.56 | 2024 | |
| Conmed Corporation | $22.37 | 2023 | Airseal |
| Misonix INC | $21.53 | 2019 | |
| Digestive Care, INC. | $21.52 | 2021 | |
| Nestle Healthcare Nutrition INC. | $21.04 | 2022 | |
| Teleflex LLC | $21.00 | 2024 | Deknatel |
| Becton, Dickinson and Company | $20.94 | 2025 | Arista |
| Bard Access Systems, INC. | $20.80 | 2019 | |
| Elutia, INC. | $19.46 | 2019 | |
| Allergan, INC. | $19.35 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.19 | 2022 | |
| Innovation Technologies INC | $18.84 | 2024 | Irrisept |
| Mauna Kea Technologies, INC. | $18.61 | 2024 | |
| Abbvie INC. | $16.93 | 2023 | |
| Smith+Nephew, INC. | $15.24 | 2019 | |
| Medtronic, INC. | $15.21 | 2023 | Progrip |
| Urgo Medical North America, LLC | $13.64 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| La Jolla Pharmaceutical Company | $13.37 | 2021 | |
| Baudax Bio INC. | $12.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Gogia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.